EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mechanism of the antidiabetic action of Nigella sativa and Thymoquinone: a review

Arslan Shaukat, Arsalan Zaidi, Haseeb Anwar, Nadeem Kizilbash

Frontiers in Nutrition · 25.09.2023 · 10

DOI: 10.3389/fnut.2023.1126272 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Nutrition, online erschienen am 25.09.2023. Verfasst von Arslan Shaukat und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Government College University - GCU, Faisalabad, Punjab, Pakistan. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 369 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Long used in traditional medicine, Nigella sativa (NS; Ranunculaceae) has shown significant efficacy as an adjuvant therapy for diabetes mellitus (DM) management by improving glucose tolerance, decreasing hepatic gluconeogenesis, normalizing blood sugar and lipid imbalance, and stimulating insulin secretion from pancreatic cells. In this review, the pharmacological and pharmacokinetic properties of NS as a herbal diabetes medication are examined in depth, demonstrating how it counteracts oxidative stress and the onset and progression of DM.

Methods

This literature review drew on databases such as Google Scholar and PubMed and various gray literature sources using search terms like the etiology of diabetes, conventional versus herbal therapy, subclinical pharmacology, pharmacokinetics, physiology, behavior, and clinical outcomes.

Results

The efficiency and safety of NS in diabetes, notably its thymoquinone (TQ) rich volatile oil, have drawn great attention from researchers in recent years; the specific therapeutic dose has eluded determination so far. TQ has anti-diabetic, anti-inflammatory, antioxidant, and immunomodulatory properties but has not proved druggable. DM’s intimate link with oxidative stress, makes NS therapy relevant since it is a potent antioxidant that energizes the cell’s endogenous arsenal of antioxidant enzymes. NS attenuates insulin resistance, enhances insulin signaling, suppresses cyclooxygenase-2, upregulates insulin-like growth factor-1, and prevents endothelial dysfunction in DM.

Conclusion

The interaction of NS with mainstream drugs, gut microbiota, and probiotics opens new possibilities for innovative therapies. Despite its strong potential to treat DM, NS and TQ must be examined in more inclusive clinical studies targeting underrepresented patient populations.

Schlagwörter

Stichwörter der Autor:innen

Nigella sativaanti-glycemicantioxidantdiabetes mellitusgut microbiotathymoquinone

Autor:innen und Institutionen

  • Department of Physiology, Government College University - GCU, Faisalabad, Punjab, Pakistan.
  • National Probiotic Laboratory, National Institute for Biotechnology and Genetic Engineering College - NIBGE-C, Faisalabad, Punjab, Pakistan.
  • Pakistan Institute of Engineering and Applied Sciences - PIEAS, Nilore, Islamabad, Pakistan.
  • Department Medical Laboratory Technology, Faculty of Applied Medical Sciences, Northern Border University, Arar, Saudi Arabia.

Zitieren

APA

Shaukat, A., Zaidi, A., Anwar, H., & Kizilbash, N. (2023). Mechanism of the antidiabetic action of Nigella sativa and Thymoquinone: a review. Frontiers in Nutrition, 10. https://doi.org/10.3389/fnut.2023.1126272

Vancouver

Shaukat A, Zaidi A, Anwar H, Kizilbash N. Mechanism of the antidiabetic action of Nigella sativa and Thymoquinone: a review. Frontiers in Nutrition. 2023;10. doi:10.3389/fnut.2023.1126272

BibTeX
@article{Shaukat2023,
  author = {Shaukat, Arslan and Zaidi, Arsalan and Anwar, Haseeb and Kizilbash, Nadeem},
  title = {Mechanism of the antidiabetic action of Nigella sativa and Thymoquinone: a review},
  journal = {Frontiers in Nutrition},
  year = {2023},
  volume = {10},
  doi = {10.3389/fnut.2023.1126272}
}
Kostenlos starten →